BRIEF-TESARO announces U.S. FDA approval of zejula for women with recurrent ovarian cancer
March 27 TESARO Inc -
* TESARO announces U.S. FDA approval of zejula™ (niraparib) for women with recurrent ovarian cancer
* TESARO anticipates launching zejula in United States in late April
* Marketing authorisation application for niraparib is under review by European Medicines Agency Source text for Eikon: Further company coverage:
REFILE-Sprint in exclusive talks with Charter, Comcast on wireless deal -WSJ
June 26 Sprint Corp is in exclusive talks with Charter Communications Inc and Comcast Corp to explore a deal that could boost the cable companies' wireless service, The Wall Street Journal reported, citing people familiar with the matter.
UPDATE 3-U.S. slaps dumping duties on Canadian wood, Ottawa vows to fight
WASHINGTON, June 26 Escalating a trade dispute with Canada in the run-up to talks on renegotiating NAFTA, the U.S. Commerce Department on Monday imposed preliminary anti-dumping duties on Canadian softwood lumber of up to 7.72 percent.